LIVING IN RESIDENTIAL INSTITUTION

This adverse event was reported 1877 times

These drugs are most commonly taken by patients reporting LIVING IN RESIDENTIAL INSTITUTION:

# Drug Count
0 CLOZAPINE 367
1 CINACALCET HYDROCHLORIDE 214
2 CARBIDOPA AND LEVODOPA 171
3 DENOSUMAB 91
4 DARBEPOETIN ALFA 59
5 DALFAMPRIDINE 56
6 ASPIRIN 55
7 PIMAVANSERIN TARTRATE 55
8 ASPIRIN 325 MG 53
9 ASPIRIN 81 MG 53
See all common drugs associated with LIVING IN RESIDENTIAL INSTITUTION

LIVING IN RESIDENTIAL INSTITUTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARBIDOPA, LEVODOPA AND ENTACAPONE 4 0.0083
1 CINACALCET HYDROCHLORIDE 214 0.0046
2 CARBIDOPA LEVODOPA 13 0.0037
3 CARBIDOPA AND LEVODOPA 171 0.0036
4 SELENIUM SULFIDE 3 0.0032
5 CLOZAPINE 367 0.0029
6 FLUDROCORTISONE ACETATE 6 0.0027
7 ENTACAPONE 11 0.0026
8 BRENSOCATIB 7 0.0025
9 AMIKACIN 25 0.0014
See all drugs enriched for association with LIVING IN RESIDENTIAL INSTITUTION